Co-Enrolment

Below is a list of trials with which ABBRUPT can co-enrol. 

  • ABC - a post ICU anaemia management trial
  • ASPECT
  • Awake Prone
  • CoReCCT
  • FLO ELA
  • FRECycl-D
  • GENOMICC. Site staff must ensure co-enrolment to GENOMIC is recorded in the patient's medical notes
  • GUARDS
  • iRehab
  • INFINIT
  • MARCH
  • MOSAICC
  • REMAP-CAP
  • RELEASE
  • SOStrial
  • SepTiC
  • SHORTER
  • T4P
  • TrAFFIC 
  • UKAR
  • UK NAVA 
  • UK-ROX
  • VITDALIZE

The following trials can NOT co-enrol with ABBRUPT.

  •  EVIS

 

The respective trial management groups of ABBRUPT and the above trials have reached a formal agreement to co-enrol or not by taking into consideration the following issues:

  • Study design and statistical considerations
  • Biological and scientific considerations
  • Possible drug interactions and any additional safety reporting
  • Implications of co-enrolment on participants and their relatives
  • Legal and ethical issues
  • Logical and organisational considerations

Please contact the trial office if interested in co-enrolling with ABBRUPT.